Page last updated: 2024-10-18

imidazole and Retinoblastoma

imidazole has been researched along with Retinoblastoma in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Retinoblastoma: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yan, S1
Yan, J1
Liu, D1
Li, X1
Kang, Q1
You, W1
Zhang, J1
Wang, L1
Tian, Z1
Lu, W1
Liu, W1
He, W1

Other Studies

1 other study available for imidazole and Retinoblastoma

ArticleYear
A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity.
    Theranostics, 2021, Volume: 11, Issue:14

    Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Chemical Engineering; Gold; Humans; Hydrogen-Io

2021